Clinical outcomes of low‐dose pharmacokinetic‐guided extended half‐life versus low‐dose standard half‐life factor VIII concentrate prophylaxis in haemophilia A patients-Reference-Cited by-同舟云学术

Clinical outcomes of low‐dose pharmacokinetic‐guided extended half‐life versus low‐dose standard half‐life factor VIII concentrate prophylaxis in haemophilia A patients

Published:2022-11-21 Issue:1 Volume:29 Page:156-164
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Rakmanotham Arunothai¹²,Moonla Chatphatai³⁴^ORCID,Sosothikul Darintr¹²^ORCID

Affiliation:

1. Division of Pediatric Hematology and Oncology Department of Pediatrics Faculty of Medicine Chulalongkorn University Bangkok Thailand

2. Integrative and Innovative Hematology/Oncology Research Unit Department of Pediatrics Faculty of Medicine Chulalongkorn University Bangkok Thailand

3. Division of General Internal Medicine Department of Medicine Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Bangkok Thailand

4. Center of Excellence in Translational Hematology Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital Bangkok Bangkok Thailand

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14700

Reference17 articles.

1. Definitions in Hemophilia

2. New therapies for hemophilia

3. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

4. WFH Guidelines for the Management of Hemophilia, 3rd edition

5. Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between natural rubber knee support and sponge knee support on the protection of knee joint: A crossover randomized controlled study among patients with bleeding disorders;Health Science Reports;2024-04

2. Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis;Orphanet Journal of Rare Diseases;2024-03-26

3. Pharmacokinetic-guided versus standard prophylaxis in hemophilia: a systematic review and meta-analysis;Journal of Thrombosis and Haemostasis;2023-12

4. Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis;2023-09-06